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R E V I E W
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Medication Adherence and Clinical Outcomes in 
Patients with Long-Term Medical Conditions
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Background: This study aims to identify interventions used to reduce medication regimen 
complexity and to assess their impact on medication adherence and clinical outcomes.
Methods: A literature search was conducted using pre-defined search terms in three 
scientific databases, including ScienceDirect, ProQuest and MEDLINE. Original research 
articles published in English between 2009 and 2020 that assessed the impact of medication 
regimen simplification on medication adherence in patients with long-term medical condi-
tions were eligible for inclusion. Review articles, meta-analysis studies and conference 
proceedings were excluded. Data charting was done in an iterative process using a study- 
specific extraction form.
Results: Of the 684 studies identified through initial searches, 17 studies were included in 
the review. Nine studies involved simplification of medication regimen related to HIV, while 
three studies focused on patients with diabetes with or without coronary artery disease. The 
remaining five studies included medications used among elderly patients or medications 
related to hypertension, psychiatric disorders, glaucoma and kidney diseases. Three medica-
tion regimen simplification strategies were identified; fixed-dose combination (n = 7), once- 
daily dosing (n = 4) and the combination of both fixed-dose and once-daily dosing (n = 6). 
Overall, most of the regimen simplification strategies (14 out of 17) were found to be useful 
in improving medication adherence. There was no assessment of clinical outcomes in four 
out of 17 studies. Furthermore, more than half of the studies that assessed clinical outcomes 
did not show any additional impact on clinical outcomes.
Conclusion: The findings suggest that there was an equal utilization of the three main 
approaches of regimen simplifications; fixed-dose combination, once-daily dosing and 
a combination of both. Overall, most of the regimen simplification strategies were found 
to be effective in improving medication adherence. However, the associated improvement 
in medication adherence did not extend to improvement in the clinical outcomes.
Keywords: medication adherence, regimen simplification, clinical outcomes, review
Introduction
Non-adherence to prescribed medications has generally been accepted as a barrier to 
the effectiveness of prescription treatment in the management of long-term medical 
conditions.1 Non-adherence to prescribed medications is prevalent among patients on 
long-term therapeutic plan and is associated with an increased risk of hospitalization 
and mortality risks.2 Medication regimen complexity has been identified as one of the 
significant contributors to the prevalence of non-adherence.3 The number and 
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frequency of daily prescribed medications are among the 
typical elements of assessing the complexity of a prescribed 
regimen.4 Regimen complexity is commonly seen among 
patients with long-term therapeutic needs for conditions 
such as HIV, diabetes, hypertension, and asthma.5–8
Additionally, complex regimens are common in the 
ageing population due to the prevalence of multiple 
comorbidities that consequently increase the need for 
polypharmacy.9 Furthermore, frequent hospitalizations 
lead to changes in the drug therapy regimen, particularly 
post-hospital discharge, which at times becomes more 
complex due to the initiation of newly prescribed 
medicines.10 Furthermore, an Italian study that assessed 
the association of regimen complexity with the risk of 
medication non-adherence suggested that regimen com-
plexity had an independent association with the relative 
non-adherence risk.11 Consequently, it has been reported 
that the interventions to reduce regimen complexity are 
sought to have a potential impact on the level of medica-
tion adherence.12
Medication regimen simplification is one of the viable 
strategies that can be employed to reduce the regimen 
complexity by minimizing the number of prescribed med-
ications through interventions such as the fixed-dose com-
bination (FDC).13 Another approach to regimen 
simplification focuses on reducing the frequency of the 
prescribed medications to a once-daily regimen where 
feasible.14 However, little has been known about the char-
acteristics and effectiveness of the regimen simplifications 
implemented in clinical practice. This review, therefore, 
aims to assess the impact of medication regimen simplifi-
cation strategies on medication adherence as well as to 
investigate their associated impact on clinical outcomes in 
patients with long-term medical conditions. Furthermore, 
it aims to characterize the types of studies based on the 
study population and prescribed medications that have 
been considered as part of regimen simplification 
interventions.
Methods
Search Strategy and Identification of the 
Studies
Three scholarly databases, ScienceDirect, ProQuest, and 
MEDLINE, were searched to identify potentially relevant 
studies. The search terms used were “Medication simplifi-
cation AND adherence OR compliance” or “Regimen 
simplification AND adherence OR compliance”. Besides, 
terms related to interventions to reduce medication regi-
men complexity were also reviewed for the possibility to 
be included only if the main intervention was regimen 
simplification. Original research articles that have been 
published between 2009 and 2020 and reported the imple-
mentation of regimen simplification strategies on adult 
patients with medication regimen complexity were 
included. The searches were limited to the last ten years 
to provide a review of the most recently published evi-
dence. Only the studies that were measuring patients` 
adherence following medication regimen simplification 
were considered. Meanwhile, studies that were only mea-
suring patients` satisfaction or acceptance based on regi-
men simplification were excluded. Furthermore, review 
articles, meta-analysis, book chapters and conference pro-
ceedings were excluded. The flowchart of the selection of 
the studies is presented in Figure 1.
Study Selection and Data Extraction
Two independent reviewers reviewed the studies based on 
titles and abstracts following the removal of duplicates. 
The eligible studies were identified and retrieved at full- 
text to consider them for inclusion. A series of meetings, 
in the beginning, at the middle and end of the data extrac-
tion process was conducted to ensure consistency. Any 
differences were resolved by the inclusion of a third 
reviewer. Data were extracted from the selected studies 
in two stages. The first stage collected information regard-
ing the main study elements, which are the author’s name, 
country, year, study design, study population, and study 
objectives. The second stage extracted information on the 
implemented simplification strategy and outcome mea-
sures for adherence and clinical outcomes. For each of 
the selected studies, the rationale for simplifying the med-
ication regimen was identified. Furthermore, the impact of 
regimen simplification on the outcome measures was 
extracted. A descriptive analysis of the extracted data 
was performed. Reporting of the key findings was carried 
out in a consistent pattern with the investigated regimen 
simplification strategies and outcome measures. Further 
summarization of the adopted approach for simplification, 
methods of measuring medication adherence and clinical 
outcomes and the overall impact of the implemented regi-
men simplifications were provided.
Results
Of the 684 studies identified through the searches, a total of 
17 studies were selected and included in this review. Nine 
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studies (53%) investigated the simplification of medication 
regimen in HIV patients,6,15–22 and three studies (18%) 
involved medication simplification among patients with 
type 2 diabetes mellitus with or without coronary artery 
disease (CAD).7,23,24 The remaining five studies (29%) 
included patients with different conditions such as venous 
thromboembolism (VTE), psychiatric disorder, glaucoma, 
kidney transplant and residents of aged care 
facilities.10,13,14,25,26 Almost all the studies reported direct 
measures of adherence except three studies that reported the 
potential improvement of adherence as a result of decreasing 
treatment burden,23 increase medication exposure,24 and 
reduce the time of medication administration.26 Thirteen of 
the seventeen studies reported clinical outcomes associated 
with the simplification of drug regimen, while four studies 
reported adherence measures with no clinical outcomes. 
Table 1 shows the characteristics of the studies that focused 
on the simplification of antiretroviral therapy (ART) 
regimens.
Simplification of Drug Regimens in 
Chronic Medical Conditions
Nine studies were identified that reported on simplification 
of ART drug regimens. Of these, four were conducted in 
the US,6,16,17,21 two in Spain,15,19 and one each in Italy, 
Brazil and Malaysia.18,20,22 Three of the studies were 
randomized trials,17,20,21 four retrospective 
studies6,18,19,22 while two were prospective cohort 
analyses.15,16 In six studies, medication regimen simplifi-
cation improved medication adherence.6,15,18,20–22 One 
study did not assess the clinical outcomes associated 
with regimen simplification.19 On the other hand, eight 
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Figure 1 The process of identification, screening, and inclusion of papers for this review.
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Study Design Study Population Objectives/Rationale




75 patients on ARV regimens. Examine the impact of pharmacist’s intervention on 
adherence and clinical outcomes of ARV regimens.
Rubio et al 
201015 
Spain
Prospective cohort study 183 HIV-infected patients on protease 
inhibitors (PIs) therapy.
Determine the effectiveness and adherence and of 
simplified once-daily dosing of atazanavir boosted with 
ritonavir (ATV/r).
Buscher 
et al 201216 
USA
Prospective cohort study 99 newly diagnosed HIV patients. To determine the effect of ART dosing frequency and 
number of pills on the adherence of newly diagnosed 
HIV patients.




476 HIV-1 RNA suppressed patients To examine the efficacy of antiretroviral simplification 
from a ritonavir-boosted protease inhibitor therapy 
(NRTI) to STR.
Fabbiani 




553 patients on EFV containing regimens. Determine the risk of therapy interruption of STR 
compared to BID or OD EFV therapy.
Arroyo et al 
201619 
Spain
Retrospective study 264 patients on ART treatment Evaluate the influence of the number of daily pills and 
daily doses on treatment adherence in a 7-year 
pharmaceutical care program.
Velvanathan 
et al 201620 
Malaysia
Randomized control trial. 120 of HIV patients Compare the clinical outcomes, adherence of patients 
on FDC vs FRC containing emtricitabine (FTC), 
tenofovir (TDF), and efavirenz (EFV).
Chen et al 
201721 USA
Randomized control trial Involved 750 HIV patients. To assess adherence barriers in correlation with STR, 
single-dose MTR, and multi-dose MTR of ART.
Laliberte’ 




5756 patients with venous 
thromboembolism (VTE).
Evaluate the adherence rates between OD and BID 
chronic medication regimens for DM and HTN in 
patients with VTE.





240 adult inpatients with HTN, DM, and/or 
dyslipidemia.
To examine the impact of structured pharmacist’s 
intervention on healthcare providers on reducing the 
complexity of the medication regimen.
Pauly et al 
201510 
Germany
Prospective open clinical 
trial
269 psychiatric patients. Assess the effect of multi-dimensional interventions in 






81 adult patients diagnosed with open-angle 
glaucoma or ocular hypertension.
To assess the adherence of TTFC with unfixed agents 
of travoprost and timolol (TRAV+ TIM).





62 patients with T2DM. Assess the impact of switching insulin therapy from 
MDI to the once-daily fixed-ratio combination.
Oh C.K et al 
202025 
South Korea
Prospective cohort trial 160 kidney transplant recipients. Evaluate the medication adherence of tacrolimus, 
sirolimus, and corticosteroids as a simplified once-daily 
immunosuppressive regimen.
(Continued)
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of drug regimens related to other medical conditions. 
These included three that were conducted in the 
US,13,14,24 two in Germany,7,10 and one each in Hungary, 
Australia and South Korea.23,25,26 There were four pro-
spective clinical trials,7,10,23,25 two randomized trials,13,26 
and two retrospective cohort studies.14,24 Three of the 
studies (3/8) in this category did not assess the clinical 
outcomes associated with regimen simplifications.
Impact of Simplification Strategies on 
Outcome Measures
With regards to ART regimens, a single-tablet regimen and 
fixed-dose combination were reported in five 
studies.17,18,20–22 Two studies simplified the medication 
regimen using once-daily dosing.15,16 Another two studies 
considered simplification by reducing both the number and 
frequency of given medications.6,19 Regarding the simpli-
fication for regimens other than ART regimens, four stu-
dies simplified regimen by adopting a single 
approach.13,14,24,25 Whereas in the other four studies, 
mixed simplification strategies were 
implemented.7,10,23,26 Table 2 provides an overview of 
the simplification strategies for regimens of different con-
ditions and their impact on outcome measures.
Discussion
In a recent meta-analysis, the association between the degree of 
medication complexity and the clinical outcomes of hospitali-
sation, hospital readmission and medication non-adherence 
across different studies has been reported.27 Furthermore, 
a recent systematic review on the medication adherence inter-
ventions highlighted the need to focus on the interventions that 
deemed to be effective to improve adherence such as medica-
tion regimen simplification, education and reminders.28 
However, to the author’s knowledge, this is the first study 
that has assessed the impact of medicine regimen simplifica-
tion strategies on medicine adherence and clinical outcomes in 
patients with long-term medical conditions. This study identi-
fied three strategies that were used to reduce the complexity of 
medication regimens; fixed-dose combination, once-daily dos-
ing and a combination of more than one approach. Overall, 
most of the regimen simplification strategies were found to be 
useful in improving medicine adherence. Although it can be 
expected that improving medicine adherence would positively 
impact clinical outcomes, the findings of this study suggest that 
clinical outcomes were not consistently enhanced by regimen 
simplification in a pattern that is consistent with an improve-
ment in medicine adherence.
Fixed Dosed Combination/Single Tablet 
Regimen
The medication regimen factors such as the dosing frequency 
and the degree of medication regimen complexity have been 
highlighted as factors affecting medication adherence among 
patients on chronic therapies.29 Moreover, in a recent systema-
tic review that investigated the association between medication 
regimen complexity and adherence to the prescribed pharma-
cotherapy, a decrease in medication adherence was observed 




Study Design Study Population Objectives/Rationale




170,024 patients with diabetes, CAD, or 
both.
To assess the effect of promoting a bundle of fixed 
doses of a generic statin and angiotensin-converting 
enzyme inhibitor/angiotensin receptor blocker (ACEI/ 
ARB),
Sluggett 
et al 202026 
Australia
Pre-planned secondary 
analysis of a cluster 
randomized controlled 
trial
242 residents of eight residential aged care 
facilities (simplification was done for 62 
residents in interventional arm)
To evaluate the impact of a medication regimen 
simplification on medication administration times, falls, 
hospitalization and mortality at 12 months follow up.
S.F Dos 
Santos 




1206 patients using MTR of efavirenz, 
tenofovir and lamivudine who switched to 
the STR.
To evaluate the impact of switching from MTR to STR 
on adherence to cART.
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Angela et al 
20106 USA
Reducing pill burden 
and dosing frequency
Refill records CD4 count Increase treatment adherence and improve clinical 
outcomes.
Rubio et al 
201015 
Spain
Once-daily dosing Self-reported Assessment of 
virological failure
Retained virological response with a slight improvement 
in adherence.
Buscher 
et al 201216 
USA
Once-daily dosing Visual analogue 
scale.
Assessment of 
treatment failure (HIV- 
RNA levels)
Greater adherence with no difference in clinical 
outcomes.
Palella et al 
201417 USA




Maintained virological suppression. No difference in 
adherence.
Fabbiani 
et al 201418 
Italy




Higher adherence and lower virological failure
Arroyo et al 
201619 
Spain
Reducing daily doses 
and pills
Dispensing records No assessment Higher adherence levels.
Velvanathan 




Morisky scores CD4 count Improved clinical outcomes and patients` adherence.
Chen et al 
201721 USA
Single tablet regimen Pill counts CD4 count Viral load 
((HIV-RNA levels)
Higher medication adherence and lower viral load
Laliberte’ 
et al 201314 
USA
Once-daily dosing MPR and PDC > 
80%
No assessment Higher adherence
Stange et al 
20137 
Germany
Reducing the number 




No assessment No significant change in adherence.













Dosing aid records IOP reduction Better adherence. IOP reductions were similar.










Effective decreased treatment burden and may improve 
adherence to therapy.
Oh C.K et al 
202025 
South Korea





Improved adherence without risk of treatment failure.
(Continued)
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with the increase in medication regimen complexity.30 
Therefore, interventions to simplify the prescribed regimens 
in either dose or frequency were thought to be helpful to show 
a favourable impact on overall medication adherence among 
a wide range of patients with chronic conditions such as 
epilepsy, schizophrenia, dyslipidemia, hypertension, diabetes 
and HIV.31–36 The importance of medication adherence in HIV 
patients cannot be overemphasized. Non-adherence to ART 
treatment would lead to resistance and treatment failure.21 
Therefore, it is crucial to ensure that HIV-infected patients 
comply with their treatment appropriately. Fixed dosed com-
bination (FDC) combines more than a single agent in one 
formulation and this generally reduces the number of pills to 
be consumed, consequently eliminating the need to administer 
multiple medications.
Our work demonstrated that there was considerable work 
on medication regimen simplifications for patients with HIV 
compared to all other chronic conditions. In this review, FDC 
was used in seven studies and five of them involved ART 
regimens. In a study conducted in the US that involved HIV 
patients, the simplification of the regimen had no impact on 
adherence; however, it showed similar effectiveness com-
pared to the conventional regimen.17 One possible reason for 
the lack of effect on adherence could be the use of a visual 
analogue scale (VAS) to measure adherence. Finitsis et al 
highlighted that VAS as a measure for adherence had a small 
association with clinical outcomes and needs further metho-
dological verification.37
On the contrary, an Italian study reported that a simplified 
ART regimen was associated with less treatment interruption 
and better effectiveness.18 Similarly, in a recent US study, 
a simplified regimen of ART therapy involving Single-Tablet 
Regimen (STR) was reported to be associated with higher 
adherence levels and better clinical outcomes.21 In addition, 
a study conducted in Malaysia also reported that the FDC of the 
ART regimen was associated with an increase in clinical out-
comes and adherence levels.20 In the context of ART regimens, 
convenient methods that reduce the number of daily pills 
increased medicine adherence and improved clinical out-
comes. It is essential to highlight that the primary aim of 
most of the studies was to provide a more convenient thera-
peutic option that could at least maintain the same level of viral 
suppression. However, some studies reported improvement in 
clinical outcomes, in addition to an increase in adherence 
levels.18,20,21
Apart from ART regimens, a study conducted by Barnebey 
et al reported a significant increase in adherence after simplify-
ing ophthalmology eye drops for glaucoma using a fixed-dose 
combination. However, there was no significant difference in 
clinical outcomes.13 Besides, previous studies also discussed 
the use of FDC glyburide-metformin as a simplification strat-
egy for diabetic patients in one single fixed combination to 
lessen the pill requirement, reduce treatment complexity and 
increase patients` adherence.38,39 Furthermore, studies that 
compared the adherence rate of FDC amlodipine-benazepril 
with the corresponding free-drug combinations in hypertensive 
patients, showed higher adherence in the former.40,41 It is 
therefore noticeable that the use of a fixed-dose combination 
is more reported in the context of simplifying the ART regi-
mens with a high probability of improving adherence and at 
least maintain the same clinical outcomes. Furthermore, it 
seems to be a reasonable simplification strategy in a range of 



















Risk of hospitalization 
for MI or stroke in the 
following year.
Higher medication exposure and decreased risk of MI or 
stroke hospitalization.
Sluggett 









Risk of falls, 
hospitalization, and 
mortality.
Significant reduction of medication administration times. 
Higher risk of falls. No significant differences were 
observed for risk of hospitalization or mortality.
Dos Santos 
et al 202022 
Brazil
Single tablet regimen Proportion of days 
covered 
(PDC≥95%)
Viral load Significant increase in adherence levels with no difference 
in viral load outcomes
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other medical conditions that require regular use of multiple 
medications such as diabetes, hypertension and glaucoma.
Once-Daily Dosing
The once-daily (OD) dosing frequency is an approach that 
reduces regimen complexity with evidence showing a higher 
adherence rate with OD dosing.14,19,25,42,43 In a metanalysis 
conducted to investigate the impact of dosing frequency on the 
medication adherence among patients with chronic CVD, the 
findings showed that approximately the once-daily dosing of 
the prescribed pharmacotherapy was associated with 50% 
decrease in the non-adherence risk although the impact on 
clinical outcomes was not well established.44 The approach 
of simplifying medication using the OD dosing regimen was 
identified in four included studies. In a Spanish study, it was 
observed that simplification to once-daily dosing ART regimen 
was associated with better clinical outcomes and with slight 
variation in the self-reported adherence.15 In contrast, Buscher 
et al showed that a simplified once-daily ART regimen had no 
impact on clinical outcomes despite the improvement in the 
adherence measured by VAS.16 On the other contrary, a US 
study that investigated the impact of OD simplification on the 
adherence to hypertensive and anti-diabetic medications 
reported a positive effect on medicine adherence.14 In this 
study, there was no assessment for clinical outcomes. 
Furthermore, in a study aimed at simplifying immunosuppres-
sant regimens for kidney transplant patients, it was found that 
OD simplified regimens were associated with a higher level of 
self-reported adherence with no risk of treatment failure.25
Similarly, a study involving anti-asthmatic medications 
carried out by Kuna et al43 in 2005 showed a greater 
impact of adherence on the maintenance therapy of OD 
budesonide-formoterol due to its convenient administra-
tion. The OD dosing may specifically be appropriate for 
patients with mild asthma who are reported to neglect their 
maintenance therapy during the symptom-free period.43 
After all, simplified dosing frequency does influence 
a patient’s compliance with long-term medication therapy.
Combination of More Than One 
Simplification Strategy
In six studies, the simplification strategies used 
a combination of both decreasing the pills burden and 
dosing frequency. It has been reported that both adherence 
and clinical outcomes are enhanced following the simpli-
fication of the ART regimen.6 Similar findings for adher-
ence have also been reported by researchers in Spain.19 
Concerning oral diabetic and hypertensive medications, 
a combined simplification strategy was not associated 
with a noticeable impact on adherence.7 However, the 
combined simplification intervention was associated with 
improvement in adherence with regards to injectable 
insulins.23 Similar positive impact on adherence to anti-
psychotic medications was also reported in a German 
study that used a combined simplification strategy.10
Interestingly, a study that showed the effect of OD 
dosing of ART regimen on adherence, the researcher did 
compare it to a fixed-dose combination of this OD dosing 
but failed to show any noticeable difference.16 It is impor-
tant to highlight that the implemented simplification strat-
egy to enhance the adherence among psychiatric patients 
was part of multidimensional interventions including 
counselling and comprehensive medication review. 
Overall, in this category, the adherence levels were most 
likely to be improved, but the clinical outcomes were not 
reported or experienced modest improvement.
In a recent Australian study that involved an overall 
eight aged care facilities, the simplifaction was adopted 
mainly through the use of long-acting and combination 
regimens where available.26 Unlike other studies that had 
a medication or regimen in the focus of the simplification, 
this Australian study was introducing the simplification as 
a feasible approach to be followed to decrease the medica-
tions burden as long as the alternatives were available. We 
acknowledge that the improvement of medication adher-
ence among elderly individuals is modulated by a broad 
spectrum of educational, behavioural factors besides the 
interventions that could be initiated and managed through 
the healthcare providers,45 Among those interventions that 
could be initiated by healthcare providers, medication regi-
men simplification was found to be a feasible and effective 
strategy, however, it requires further training and time 
allocation for better outcomes.4
The Overall Impact of Regimen 
Simplification on Adherence and Clinical 
Outcomes
Across all the seventeen studies included in this review, 
three studies reported no significant impact on adherence 
following regimen simplification.7,15,17 Noticeably in these 
three studies, the assessment of adherence was predomi-
nantly self-reported. However, future studies should be 
consistent in the use of quantitative measures for assessing 
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medicine adherence to determine the actual impact on 
adherence following regimen simplification strategies.
Unlike adherence, the impact of regimen simplification on 
clinical outcomes was not conclusive because of the lack of 
assessment of the clinical outcomes in four of the included 
studies.7,10,14,19 In addition, more than half of the remaining 
studies showed that the simplified regimens demonstrated the 
same clinical outcomes as compared to conventional regimens. 
It can, therefore, be concluded that there is relatively little 
evidence to support that regimen simplifications improve clin-
ical outcomes. This finding was consistent with a previously 
conducted meta-analysis that showed that simplification the 
prescribed pharmacotherapy was not consistently linked to 
improvement in clinical outcomes despite its positive impact 
on medication adherence.44
In a recent Jordanian study among patients with osteoporo-
sis, it has been observed that the medication non-adherence 
was affected by the increased number of prescribed 
medications.46 Therefore, a simplified regimen possibly with 
STR or fixed-dose combination might provide a reasonable 
clinical solution to improve adherence. Moreover, a meta- 
analysis by Igaly et al has indicated that once-weekly dosing 
of treatment for osteoporosis was associated with better adher-
ence levels and higher odds of being adherent as compared to 
the once-daily dosing.47
It is important to highlight that simplification of medication 
regimens does not necessarily need to be designed as interven-
tions to address problems of non-adherence. Instead, it can be 
considered an approach followed by the healthcare providers 
to initiate, change and individualise the therapeutic choices to 
be more likely encouraging patient compliance to the antici-
pated medication-taking behaviours.48 Also, previous evi-
dence has highlighted that the interventions considering other 
educational and behavioural aspects in addition to the inter-
ventions initiated by healthcare providers will more likely to 
have a relatively sustained impact on medication adherence.45 
There is sufficient evidence to support that the pharmacist 
being one of the primary healthcare providers responsible for 
improving medication adherence,49 is expected to play 
a crucial role in initiating and applying feasible interventions 
for medication regimen simplifications.4,26
This study has some limitations. Quality assessment of 
the included studies was not conducted. The searches were 
restricted to three databases that may have limited the 
opportunity to identify further eligible studies published 
in other relevant databases. Furthermore, since the study 
was limited to the inclusion of published literature only, 
publication bias is probable.
Conclusion
This review identified three main strategies used for regimen 
simplifications; fixed-dose combination, once-daily dosing, 
and a combination of both fixed-dose combination and once- 
daily dosing. Overall, the strategies were found to be useful 
and feasible to improve medication adherence. However, 
clinical outcomes were not consistently improved by regi-
men simplification interventions in a pattern that is consistent 
with the increase in adherence. Future work may be directed 
at refining the use of feasible streamlined drug regimens with 
a greater emphasis on the impact on clinical outcomes.
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